704 related articles for article (PubMed ID: 28527063)
1. The role of anti-CGRP antibodies in the pathophysiology of primary headaches.
Barbanti P; Aurilia C; Fofi L; Egeo G; Ferroni P
Neurol Sci; 2017 May; 38(Suppl 1):31-35. PubMed ID: 28527063
[TBL] [Abstract][Full Text] [Related]
2. CGRP, a target for preventive therapy in migraine and cluster headache: Systematic review of clinical data.
Khan S; Olesen A; Ashina M
Cephalalgia; 2019 Mar; 39(3):374-389. PubMed ID: 29110503
[TBL] [Abstract][Full Text] [Related]
3. Calcitonin Gene-Related Peptide-Targeted Therapies for Migraine and Cluster Headache: A Review.
Schuster NM; Rapoport AM
Clin Neuropharmacol; 2017; 40(4):169-174. PubMed ID: 28644160
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin gene-related peptide antagonism and cluster headache: an emerging new treatment.
Ashina H; Newman L; Ashina S
Neurol Sci; 2017 Dec; 38(12):2089-2093. PubMed ID: 28856479
[TBL] [Abstract][Full Text] [Related]
5. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review.
Yuan H; Spare NM; Silberstein SD
Headache; 2019 Jul; 59 Suppl 2():20-32. PubMed ID: 31291020
[TBL] [Abstract][Full Text] [Related]
6. CGRP Monoclonal Antibodies for the Preventative Treatment of Migraine.
Israel H; Neeb L; Reuter U
Curr Pain Headache Rep; 2018 Apr; 22(5):38. PubMed ID: 29623520
[TBL] [Abstract][Full Text] [Related]
7. Migraine and cluster headache - the common link.
Vollesen AL; Benemei S; Cortese F; Labastida-Ramírez A; Marchese F; Pellesi L; Romoli M; Ashina M; Lampl C;
J Headache Pain; 2018 Sep; 19(1):89. PubMed ID: 30242519
[TBL] [Abstract][Full Text] [Related]
8. Spotlight on Anti-CGRP Monoclonal Antibodies in Migraine: The Clinical Evidence to Date.
Pellesi L; Guerzoni S; Pini LA
Clin Pharmacol Drug Dev; 2017 Nov; 6(6):534-547. PubMed ID: 28409893
[TBL] [Abstract][Full Text] [Related]
9. CGRP pathway monoclonal antibodies for cluster headache.
Chan C; Goadsby PJ
Expert Opin Biol Ther; 2020 Aug; 20(8):947-953. PubMed ID: 32241175
[TBL] [Abstract][Full Text] [Related]
10. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development.
Bigal ME; Walter S; Rapoport AM
Headache; 2013 Sep; 53(8):1230-44. PubMed ID: 23848260
[TBL] [Abstract][Full Text] [Related]
11. History and Review of anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: From Translational Research to Treatment.
Tepper SJ
Headache; 2018 Nov; 58 Suppl 3():238-275. PubMed ID: 30242830
[TBL] [Abstract][Full Text] [Related]
12. CGRP Monoclonal Antibodies for Migraine: Rationale and Progress.
Yuan H; Lauritsen CG; Kaiser EA; Silberstein SD
BioDrugs; 2017 Dec; 31(6):487-501. PubMed ID: 29116598
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies for migraine: preventing calcitonin gene-related peptide activity.
Bigal ME; Walter S
CNS Drugs; 2014 May; 28(5):389-99. PubMed ID: 24638916
[TBL] [Abstract][Full Text] [Related]
14. Erenumab in the treatment of migraine.
Jain S; Yuan H; Spare N; Silberstein SD
Pain Manag; 2018 Nov; 8(6):415-426. PubMed ID: 30235976
[TBL] [Abstract][Full Text] [Related]
15. Anti-CGRP and anti-CGRP receptor monoclonal antibodies as antimigraine agents. Potential differences in safety profile postulated on a pathophysiological basis.
Tringali G; Navarra P
Peptides; 2019 Jun; 116():16-21. PubMed ID: 31018157
[TBL] [Abstract][Full Text] [Related]
16. The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy.
Raffaelli B; Reuter U
Neurotherapeutics; 2018 Apr; 15(2):324-335. PubMed ID: 29616494
[TBL] [Abstract][Full Text] [Related]
17. CGRP in human models of primary headaches.
Ashina H; Schytz HW; Ashina M
Cephalalgia; 2018 Feb; 38(2):353-360. PubMed ID: 27940880
[TBL] [Abstract][Full Text] [Related]
18. Anti-CGRP monoclonal antibodies in migraine: current perspectives.
Giamberardino MA; Affaitati G; Curto M; Negro A; Costantini R; Martelletti P
Intern Emerg Med; 2016 Dec; 11(8):1045-1057. PubMed ID: 27339365
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic antibodies against CGRP or its receptor.
Bigal ME; Walter S; Rapoport AM
Br J Clin Pharmacol; 2015 Jun; 79(6):886-95. PubMed ID: 25614243
[TBL] [Abstract][Full Text] [Related]
20. Nonspecific oral medications versus anti-calcitonin gene-related peptide monoclonal antibodies for migraine: A systematic review and meta-analysis of randomized controlled trials.
Robblee J; Hakim SM; Reynolds JM; Monteith TS; Zhang N; Barad M
Headache; 2024 May; 64(5):547-572. PubMed ID: 38634515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]